IFFIm

AcronymDefinition
IFFImInternational Finance Facility for Immunization
References in periodicals archive ?
IFFIm is a supranational administrative body, which was established in 2006.
Moody's Investors Service yesterday assigned a provisional (P)Aa1 senior unsecured MTN rating to the Trust Certificate Issuance of IFFIm Sukuk Company Limited ("the Issuer"), a special purpose vehicle established in the Cayman Islands by International Finance Facility for Immunisation Company (IFFIm).
The World Bank acts as Treasury Manager for IFFIm, whilst immunisation programmes are funded by the company through GAVI, the Vaccine Alliance.
For example, only very few countries currently implement the SLAT (Unitaid, 2011); to date, few European countries have employed the Greenhouse Gas Emission Permits with relevant effects (European Commission, 2009); the Buy-Downs have only generated commitments of advanced payment from China and Botswana (OECD, 2011); In regard to the IFFIm, up until 2011, only eight countries had committed resources that allowed the issue of "vaccination bonuses" in the London and Tokyo markets (Pearson et al.
A GAVI spokesman said new vaccine bonds might be issued this year as part of a regular IFFIm capital raising.
The World Bank serves as the treasury manager for IFFIm, whose bonds are rated AAA because they are based on legally binding commitments by seven donor countries to offer grants over a 20-year period.
Funds raised on financial markets by IFFIm are disbursed as grants to Gavi, the Vaccine Alliance (Gavi), a global health public-private partnership to improve access to immunisation for children in a pool of eligible developing countries.
Moody's Investors Service has today assigned a definitive Aa1 senior unsecured bond rating (outlook stable) to the Trust Certificate Issuance of IFFIm Sukuk Company II Limited, a special purpose vehicle established in the Cayman Islands by International Finance Facility for Immunisation Company (IFFIm).
Issued in November 2014, the IFFIm (International Finance Facility for Immunisation Company) benchmark medium-term sukuk addressed a humanitarian cause with its proceeds channelled into the provision of free vaccines and health systems for the world's poorest nations.
I was pleased when IFFIm launched a $500 million debut Sukuk last year to finance projects for the Global Alliance for Vaccines and Immunisation.
IFFIm successfully raised $1 billion in November 2006 by issuing in London a five-year vaccine bond mainly to institutional investors.